Zhong Q, Zhou R, Huang YN, Huang RD, Li FR, Chen HW, et al. Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases. J Hepatol. 2025;82(3):427–37. https://doi.org/10.1016/j.jhep.2024.08.024.

Article  CAS  PubMed  Google Scholar 

Ali NA, Hamdy NM, Gibriel AA, El Mesallamy HO. Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma. Adv Virol. 2021;166(6):1643–51. https://doi.org/10.1007/s00705-021-04981-8.

Article  CAS  Google Scholar 

Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516–37. https://doi.org/10.1016/j.jhep.2023.03.017.

Article  PubMed  Google Scholar 

Abaza T, El-Aziz MKA, Daniel KA, Karousi P, Papatsirou M, Fahmy SA, et al. Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy. Int J Mol Sci. 2023;24:22. https://doi.org/10.3390/ijms242216484

Xiao J, Wang F, Yuan Y, Gao J, Xiao L, Yan C, et al. Epidemiology of liver diseases: global disease burden and forecasted research trends. Sci China Life Sci. 2025;68(2):541–57. https://doi.org/10.1007/s11427-024-2722-2.

Article  PubMed  Google Scholar 

Youssef SS, Hamdy NM. SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4. Adv Virol. 2017;162(11):3347–54. https://doi.org/10.1007/s00705-017-3498-7.

Article  CAS  Google Scholar 

El-Mesallamy HO, Hamdy NM, Rizk HH, El-Zayadi AR. Apelin serum level in Egyptian patients with chronic hepatitis C. Mediators Inflamm. 2011;2011: 703031. https://doi.org/10.1155/2011/703031.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ge WJ, Huang H, Wang T, Zeng WH, Guo M, Ren CR, et al. Long non-coding RNAs in hepatocellular carcinoma. Pathol Res Pract. 2023;248: 154604. https://doi.org/10.1016/j.prp.2023.154604.

Article  CAS  PubMed  Google Scholar 

Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359–76. https://doi.org/10.1016/s0140-6736(21)01374-x.

Article  PubMed  Google Scholar 

Hammad R, Eldosoky MA, Elmadbouly AA, Aglan RB, AbdelHamid SG, Zaky S, et al. Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(17):15349–64. https://doi.org/10.1007/s00432-023-05313-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hammad R, Aglan RB, Mohammed SA, Awad EA, Elsaid MA, Bedair HM, et al. Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma. Int J Mol Sci. 2022;23(20). https://doi.org/10.3390/ijms232012541

Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252–66. https://doi.org/10.1016/j.molcel.2022.05.027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2). https://doi.org/10.1083/jcb.202009045

Erber J, Herndler-Brandstetter D. Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer. Front Immunol. 2023;14:1181499. https://doi.org/10.3389/fimmu.2023.1181499.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiStefano JK, Gerhard GS. Long Noncoding RNAs and Human Liver Disease. Annu Rev Pathol. 2022;17:1–21. https://doi.org/10.1146/annurev-pathol-042320-115255.

Article  CAS  PubMed  Google Scholar 

Wang J, Zhang X, Chen W, Hu X, Li J, Liu C. Regulatory roles of long noncoding RNAs implicated in cancer hallmarks. Int J Cancer. 2020;146(4):906–16. https://doi.org/10.1002/ijc.32277.

Article  CAS  PubMed  Google Scholar 

Ilieva M, Uchida S. Perspectives of LncRNAs for therapy. Cell Biol Toxicol. 2022;38(6):915–7. https://doi.org/10.1007/s10565-022-09779-1.

Article  PubMed  PubMed Central  Google Scholar 

Lemos AEG, Matos ADR, Ferreira LB, Gimba ERP. The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer. Oncotarget. 2019;10(61):6589–603. https://doi.org/10.18632/oncotarget.27284.

Article  PubMed  PubMed Central  Google Scholar 

Kudriashov V, Sufianov A, Mashkin A, Beilerli A, Ilyasova T, Liang Y, et al. The role of long non-coding RNAs in carbohydrate and fat metabolism in the liver. Non-coding RNA research. 2023;8(3):294–301. https://doi.org/10.1016/j.ncrna.2023.03.003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zarandi PK, Ghiasi M, Heiat M. The role and function of lncRNA in ageing-associated liver diseases. RNA Biol. 2025;22(1):1–8. https://doi.org/10.1080/15476286.2024.2440678.

Article  CAS  PubMed  Google Scholar 

Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, et al. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Front Immunol. 2021;12: 719175. https://doi.org/10.3389/fimmu.2021.719175.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Han S, Zeng Z, Zheng H, Li Y, Wang F, et al. Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism. Theranostics. 2024;14(18):7088–110. https://doi.org/10.7150/thno.99197.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Z, Zhou JK, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19(1):77. https://doi.org/10.1186/s12943-020-01188-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin HP, Rea M, Wang Z, Yang C. Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property. Toxicol Appl Pharmacol. 2021;430: 115724. https://doi.org/10.1016/j.taap.2021.115724.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding G, Li W, Liu J, Zeng Y, Mao C, Kang Y, et al. LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma. Biomed Pharmacother. 2017;94:326–31. https://doi.org/10.1016/j.biopha.2017.07.046.

Article  CAS  PubMed  Google Scholar 

Tang J, Xie Y, Xu X, Yin Y, Jiang R, Deng L, et al. Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma. Cell Death Dis. 2017;8(3): e2675. https://doi.org/10.1038/cddis.2017.81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Gewely MR. Dysregulation of Regulatory ncRNAs and Diseases. Int J Mol Sci. 2023;25(1). https://doi.org/10.3390/ijms25010024

Xie R, Wang M, Zhou W, Wang D, Yuan Y, Shi H, et al. Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer. Med Sci Monit. 2019;25:7149–57. https://doi.org/10.12659/msm.917562.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo J, Zhang N, Liu G, Zhang A, Liu X, Zheng J. Upregulated expression of long non-coding RNA MEG3 serves as a prognostic biomarker in severe pneumonia children and its regulatory mechanism. Bioengineered. 2021;12(1):7120–31. https://doi.org/10.1080/21655979.2021.1979351.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oksuz O, Henninger JE, Warneford-Thomson R, Zheng MM, Erb H, Vancura A, et al. Transcription factors interact with RNA to regulate genes. Mol Cell. 2023;83(14):2449-63.e13. https://doi.org/10.1016/j.molcel.2023.06.012.